Shi-ming Luo
Guangzhou Key Laboratory Of Metabolic Diseases And Reproductive Health
Guangzhou, 510317, China
Guangzhou, 510317, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Corrigendum to "TRIAL-based combination therapies in cancers" [Int. Immunopharmacol. 138 (2024) 112570].
Journal: International immunopharmacology
Published: May 09, 2026
Maternal obesity disrupts epigenetic reprogramming via peroxisomal-dependent phospholipid-methyl uncoupling during zygotic genome activation.
Journal: Nature communications
Published: September 27, 2025
Maternal obesity disrupts epigenetic reprogramming via peroxisomal-dependent phospholipid-methyl uncoupling during zygotic genome activation.
Journal: Nature communications
Published: September 27, 2025
The dynamic landscape and conserved regulation of the m6Am and m6A methylomes during the human and mouse oocyte-to-embryo transition.
Journal: Nucleic acids research
Published: August 29, 2025
Ultra-low-input rG4-seq reveals the RNA G-quadruplex regulome in gene expression and genome integrity.
Journal: Nucleic acids research
Published: April 22, 2025
FAM210B activates STAT1/IRF9/IFIT3 axis by upregulating IFN-α/β expression to impede the progression of lung adenocarcinoma.
Journal: Cell death & disease
Published: May 26, 2024
TRIAL-based combination therapies in cancers.
Journal: International immunopharmacology
Published: May 20, 2024
FMNL2 regulates actin for endoplasmic reticulum and mitochondria distribution in oocyte meiosis.
Journal: eLife
Published: May 15, 2024
Continuous light exposure influences luteinization and luteal function of ovary in ICR mice.
Journal: Journal of pineal research
Published: September 09, 2022
Last Updated: 09/26/2026